Hundreds of millions of people have long-term conditions as a result of an infection. Researchers are working out how to help them
For Many Americans, Covid Is Still a Chronic, Disabling Disease. These Scientists Are Working Tirelessly to Bring Them Relief
Long Covid saps the strength and vitality of patients, who have little recourse to fight it. A team of specialists—including an afflicted researcher working mostly from her bed—is looking for answers
Long COVID Study Finds Gut Immune System Struggling to Clear Lingering Virus
LIINC researchers found evidence of persistent SARS-CoV-2 in intestinal tissue from some people with Long COVID, along with immune system changes that suggest ongoing inflammation and impaired antiviral responses.
VIPER aims to fast track Long COVID biomarkers. Here’s how it works.
Researchers at UCSF launched VIPER, a new program that aims to identify and validate reliable biomarkers by comparing promising tests across laboratories, helping advance tools that could improve Long COVID diagnosis and research.
Millions of People Live With Long COVID. This Researcher Is on a Mission to Find a Cure.
Six years ago, Dr. Michael Peluso and his team launched a first-of-its-kind long COVID tissue bank and have been working to understand the disease ever since.
Solving Long COVID: How Decades of HIV Research Paved the Way
UCSF’s rapid shift to uncover the virus’s hidden effects and seemingly unconnected symptoms put its researchers at the forefront of the field.
No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential
While three early clinical trials of these drugs – including the UCSF outSMART trial – did not find they led to health improvements for participants, further trials are getting more intentional in targeting viral persistence.
Experts Discuss Long COVID: A Guide to Understanding Infection-Associated Chronic Disease
Long COVID researchers, including LIINC Principal Investigator Dr. Michael Peluso, discuss Long COVID and other infection-associated chronic diseases as part of a special webinar hosted by Science Translational Medicine.
How Long COVID Could Lift the Fog on Neurocognitive Disorders
Dr. Michael Peluso (UCSF) and Dr. Wes Ely (Vanderbilt University) provide insights on the burden of Long COVID neurocognitive disorders and how the broadening definition of memory disorders could include Long COVID. They stress that additional funding is needed to ensure scientists have the resources needed to find answers.
Long COVID Linked to Persistent Inflammation and Viral RNA
Scientists in the United States have been scanning patients with Long COVID symptoms in a bid to assess the long-term impact of the SARS-CoV-2 virus. They’ve done it by using a special imaging technique which lights up when it sees inflammation.